Cover Image
Market Research Report

Asia-Pacific Cell-based Assays Market: Industry Trends and Forecast to 2026

Published by Data Bridge Market Research Private Limited Product code 913486
Published Content info 120 Pages
Delivery time: 1-2 business days
Price
Back to Top
Asia-Pacific Cell-based Assays Market: Industry Trends and Forecast to 2026
Published: October 1, 2019 Content info: 120 Pages
Description

Asia-Pacific cell based assays market is projected to register a substantial CAGR in the forecast period 2019 to 2026. The new market report contains data for historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation:

By Type (Cell Viability Assay, Cytotoxicity Assay, Cell Death Assay, Cell Proliferation Assay, Others), Product & Services (Consumables, Services, Instruments and Software), Technology (Flow Cytometry, High Throughput Screening, High Content Screening, Label Free Detection), Application (Drug Discovery, Basic Research, Others), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutions, Government Organizations, Others), Distribution Channel (Direct, Indirect), Country (China, Japan, South Korea, India, Singapore, Australia, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific).

Some of the major factors contributing to the growth of the market:

  • Rising demands for novel small molecules, bio-therapeutic and cell based therapies
  • increasing investments in research and development for drug discovery in Asia Pacific
  • Increasing incidence of cancer cases in Asia-Pacific region

Key Market Players:

The key market players for Asia-Pacific cell based assays market are listed below:

  • GENERAL ELECTRIC
  • Danaher
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • PerkinElmer Inc.
  • Bio-Rad Laboratories, Inc.
  • ATCC
  • Aurelia Bioscience Ltd
  • BD
  • BioAgilytix Labs
  • BioVision Inc.
  • Cell Signaling Technology, Inc
  • Cisbio
  • Enzo Biochem Inc
  • Eurofins Scientific
  • LakePharma, Inc
  • Lonza
  • Miltenyi Biotec
  • XenoDiagnostics, LLC
Table of Contents

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. OVERVIEW OF ASIA-PACIFIC CELL BASED ASSAYS MARKET
  • 1.4. LIMITATIONS
  • 1.5. MARKETS COVERED

2. MARKET SEGMENTATION

  • 2.1. MARKETS COVERED
  • 2.2. ASIA-PACIFIC CELL BASED ASSAYS MARKET: GEOGRAPHICAL SCOPE
  • 2.3. YEARS CONSIDERED FOR THE STUDY
  • 2.4. CURRENCY AND PRICING
  • 2.5. DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.7. DBMR MARKET POSITION GRID (ON THE BASIS OF PRODUCTS)
  • 2.8. DBMR MARKET POSITION GRID
  • 2.9. DBMR VENDOR SHARE ANALYSIS
  • 2.10. MULTIVARIATE MODELING
  • 2.11. PRODUCTS LIFELINE CURVE
  • 2.12. SECONDARY SOURCES
  • 2.13. ASSUMPTIONS

3. MARKET OVERVIEW

  • 3.1. DRIVERS
    • 3.1.1. INCREASING INCIDENCE OF CHRONIC DISEASES
    • 3.1.2. RISING DEMANDS FOR NOVEL SMALL MOLECULES, BIO-THERAPEUTIC AND CELL BASED THERAPIES
    • 3.1.3. INCREASE IN RESEARCH AND DEVELOPMENT EXPENDITURE
  • 3.2. RESTRAINT
    • 3.2.1. STRINGENT REGULATORY REQUIREMENTS
    • 3.2.2. HIGH COST OF INSTRUMENTATION
  • 3.3. OPPORTUNITIES
    • 3.3.1. TECHNOLOGICAL ADVANCEMENTS
    • 3.3.2. STRATEGIC INITIATIVE BY THE MARKET PLAYERS
  • 3.4. CHALLENGES
    • 3.4.1. CHALLENGING ANALYSIS PROCEDURE

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. ASIA-PACIFIC CELL-BASED ASSAYS MARKET, BY TYPE

  • 6.1. OVERVIEW
  • 6.2. CELL VIABILITY ASSAY
  • 6.3. CYTOTOXICITY ASSAY
  • 6.4. CELL PROLIFERATION ASSAY
  • 6.5. CELL DEATH ASSAY
  • 6.6. OTHERS

7. ASIA-PACIFIC CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICES

  • 7.1. OVERVIEW
  • 7.2. CONSUMABLES
    • 7.2.1. ASSAY KITS
    • 7.2.2. CELL LINES
      • 7.2.2.1. PRIMARY CELL LINES
      • 7.2.2.2. STEM CELL LINES
      • 7.2.2.3. IMMORTALIZED CELL LINES
    • 7.2.3. REAGENTS
    • 7.2.4. MICROPLATES
  • 7.3. SERVICES
  • 7.4. INSTRUMENTS AND SOFTWARE

8. ASIA-PACIFIC CELL-BASED ASSAYS MARKET, BY TECHNOLOGY

  • 8.1. OVERVIEW
  • 8.2. HIGH THROUGHPUT SCREENING
  • 8.3. FLOW CYTOMETRY
  • 8.4. HIGH CONTENT SCREENING
  • 8.5. LABEL FREE DETECTION

9. ASIA-PACIFIC CELL-BASED ASSAYS MARKET, BY APPLICATION

  • 9.1. OVERVIEW
  • 9.2. DRUG DISCOVERY
    • 9.2.1. PREDICTIVE TOXICOLOGY
    • 9.2.2. PHARMACODYNAMIC STUDIES
    • 9.2.3. ADME RESEARCH
  • 9.3. BASIC RESEARCH
  • 9.4. OTHERS

10. ASIA-PACIFIC CELL-BASED ASSAYS MARKET, BY END USER

  • 10.1. OVERVIEW
  • 10.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 10.3. CONTRACT RESEARCH ORGANIZATIONS
  • 10.4. ACADEMIC & RESEARCH INSTITUTIONS
  • 10.5. GOVERNMENT ORGANIZATIONS
  • 10.6. OTHERS

11. ASIA-PACIFIC CELL-BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL

  • 11.1. OVERVIEW
  • 11.2. DIRECT
  • 11.3. INDIRECT

12. ASIA-PACIFIC CELL BASED ASSAY MARKET, BY GEOGRAPHY

  • 12.1. ASIA-PACIFIC
    • 12.1.1. CHINA
    • 12.1.2. JAPAN
    • 12.1.3. SOUTH KOREA
    • 12.1.4. INDIA
    • 12.1.5. SINGAPORE
    • 12.1.6. AUSTRALIA
    • 12.1.7. THAILAND
    • 12.1.8. MALAYSIA
    • 12.1.9. INDONESIA
    • 12.1.10. PHILIPPINES
    • 12.1.11. REST OF ASIA-PACIFIC

13. ASIA-PACIFIC CELL BASED ASSAYS MARKET FOR PRODUCTS, COMPANY LANDSCAPE

  • 13.1. COMPANY SHARE ANALYSIS: ASIA-PACIFIC

14. ASIA-PACIFIC CELL BASED ASSAYS MARKET FOR SERVICES, COMPANY LANDSCAPE

  • 14.1. COMPANY SHARE ANALYSIS: ASIA-PACIFIC

15. COMPANY PROFILE

  • 15.1. GENERAL ELECTRIC
    • 15.1.1. COMPANY SNAPSHOT
    • 15.1.2. REVENUE ANALYSIS
    • 15.1.3. COMPANY SHARE ANALYSIS
    • 15.1.4. PRODUCT PORTFOLIO
    • 15.1.5. RECENT DEVELOPMENTS
  • 15.2. DANAHER
    • 15.2.1. COMPANY SNAPSHOT
    • 15.2.2. REVENUE ANALYSIS
    • 15.2.3. COMPANY SHARE ANALYSIS
    • 15.2.4. PRODUCT PORTFOLIO
    • 15.2.5. RECENT DEVELOPMENT
  • 15.3. AGILENT TECHNOLOGIES, INC.
      • 15.3.1.1. COMPANY SNAPSHOT
    • 15.3.2. REVENUE ANALYSIS
    • 15.3.3. COMPANY SHARE ANALYSIS
    • 15.3.4. PRODUCT PORTFOLIO
    • 15.3.5. RECENT DEVELOPMENTS
  • 15.4. THERMO FISHER SCIENTIFIC INC
    • 15.4.1. COMPANY SNAPSHOT
    • 15.4.2. REVENUE ANALYSIS
    • 15.4.3. COMPANY SHARE ANALYSIS
    • 15.4.4. PRODUCT PORTFOLIO
    • 15.4.5. RECENT DEVELOPMENT
  • 15.5. MERCK KGAA
    • 15.5.1. COMPANY SNAPSHOT
    • 15.5.2. REVENUE ANALYSIS
    • 15.5.3. PRODUCT PORTFOLIO
    • 15.5.4. RECENT DEVELOPMENT
  • 15.6. PERKINELMER INC, INC.
    • 15.6.1. COMPANY SNAPSHOT
    • 15.6.2. REVENUE ANALYSIS
    • 15.6.3. PRODUCT PORTFOLIO
    • 15.6.4. RECENT DEVELOPMENT
  • 15.7. BIO-RAD LABORATORIES, INC.
    • 15.7.1. COMPANY SNAPSHOT
    • 15.7.2. REVENUE ANALYSIS
    • 15.7.3. PRODUCT PORTFOLIO
    • 15.7.4. RECENT DEVELOPMENTS
  • 15.8. ATCC
    • 15.8.1. COMPANY SNAPSHOT
    • 15.8.2. PRODUCT PORTFOLIO
    • 15.8.3. RECENT DEVELOPMENT
  • 15.9. AURELIA BIOSCIENCE LTD.
    • 15.9.1. COMPANY SNAPSHOT
    • 15.9.2. SERVICE PORTFOLIO
    • 15.9.3. RECENT DEVELOPMENT
  • 15.10. BD
    • 15.10.1. COMPANY SNAPSHOT
    • 15.10.2. REVENUE ANALYSIS
    • 15.10.3. PRODUCT PORTFOLIO
    • 15.10.4. RECENT DEVELOPMENTS
  • 15.11. BIOAGILYTIX LABS
    • 15.11.1. COMPANY SNAPSHOT
    • 15.11.2. SERVICE PORTFOLIO
    • 15.11.3. RECENT DEVELOPMENTS
  • 15.12. BIOVISION INC.
    • 15.12.1. COMPANY SNAPSHOT
    • 15.12.2. PRODUCT PORTFOLIO
    • 15.12.3. RECENT DEVELOPMENT
  • 15.13. CELL SIGNALING TECHNOLOGY, INC.
    • 15.13.1. COMPANY SNAPSHOT
    • 15.13.2. PRODUCT PORTFOLIO
    • 15.13.3. RECENT DEVELOPMENT
  • 15.14. CISBIO
    • 15.14.1. COMPANY SNAPSHOT
    • 15.14.2. PRODUCT PORTFOLIO
    • 15.14.3. RECENT DEVELOPMENT
  • 15.15. ENZO BIOCHEM INC.
    • 15.15.1. COMPANY SNAPSHOT
    • 15.15.2. REVENUE ANALYSIS
    • 15.15.3. PRODUCT PORTFOLIO
    • 15.15.4. RECENT DEVELOPMENT
  • 15.16. EUROFINS SCIENTIFIC
    • 15.16.1. COMPANY SNAPSHOT
    • 15.16.2. REVENUE ANALYSIS
    • 15.16.3. PRODUCT AND SERVICE PORTFOLIO
    • 15.16.4. RECENT DEVELOPMENTS

  • 15.17. LAKEPHARMA, INC.
    • 15.17.1. COMPANY SNAPSHOT
    • 15.17.2. SERVICE PORTFOLIO
    • 15.17.3. RECENT DEVELOPMENT
  • 15.18. LONZA
    • 15.18.1. COMPANY SNAPSHOT
    • 15.18.2. REVENUE ANALYSIS
    • 15.18.3. SERVICE PORTFOLIO
    • 15.18.4. RECENT DEVELOPMENT
  • 15.19. MILTENYI BIOTEC
    • 15.19.1. COMPANY SNAPSHOT
      • 15.19.2.2. PRODUCT PORTFOLIO
    • 15.19.3. RECENT DEVELOPMENT
  • 15.20. XENO DIAGNOSTICS, LLC.
    • 15.20.1. COMPANY SNAPSHOT
    • 15.20.2. PRODUCT PORTFOLIO
    • 15.20.3. RECENT DEVELOPMENT

16. QUESTIONNAIRE

17. RELATED REPORTS

LIST OF TABLES

  • TABLE 1 AGEING WORLD POPULATION (IN MILLIONS)
  • TABLE 2 TABLE REGIONS BY DIABETES PREVALENCE (%) IN ELDERLY POPULATION IN 2017 AND 2045 (IN MILLIONS)
  • TABLE 3 TOP 20 PHARMA COMPANIES BY SIZE OF PIPELINE
  • TABLE 4 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 5 ASIA-PACIFIC CELL VIABILITY ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 6 ASIA-PACIFIC CYTOTOXICITY ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 7 ASIA-PACIFIC CELL PROLIFERATION ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 8 ASIA-PACIFIC CELL DEATH ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 9 ASIA-PACIFIC OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 10 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 11 ASIA-PACIFIC CONSUMABLES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 12 ASIA-PACIFIC CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 13 ASIA-PACIFIC CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 14 ASIA-PACIFIC SERVICES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 15 ASIA-PACIFIC INSTRUMENTS AND SOFTWARE IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 16 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 17 ASIA-PACIFIC HIGH THROUGHPUT SCREENING IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 18 ASIA-PACIFIC FLOW CYTOMETRY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 19 ASIA-PACIFIC HIGH CONTENT SCREENING IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 20 ASIA-PACIFIC LABEL FREE DETECTION IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 21 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 22 ASIA-PACIFIC DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 23 ASIA-PACIFIC DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 24 ASIA-PACIFIC BASIC RESEARCH IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 25 ASIA-PACIFIC OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 26 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 27 ASIA-PACIFIC PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 28 ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 29 ASIA-PACIFIC ACADEMIC & RESEARCH INSTITUTIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 30 ASIA-PACIFIC GOVERNMENT ORGANIZATIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 31 ASIA-PACIFIC OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 32 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 33 ASIA-PACIFIC DIRECT IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 34 ASIA-PACIFIC INDIRECT IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 35 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 36 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 37 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 38 ASIA-PACIFIC CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 39 ASIA-PACIFIC CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 40 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 41 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 42 ASIA-PACIFIC DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 43 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 44 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 45 CHINA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 46 CHINA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 47 CHINA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 48 CHINA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 49 CHINA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 50 CHINA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 51 CHINA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 52 CHINA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 53 CHINA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 54 JAPAN CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 55 JAPAN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 56 JAPAN CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 57 JAPAN CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 58 JAPAN CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 59 JAPAN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 60 JAPAN DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 61 JAPAN CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 62 JAPAN CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 63 SOUTH KOREA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 64 SOUTH KOREA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 65 SOUTH KOREA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 66 SOUTH KOREA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 67 SOUTH KOREA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 68 SOUTH KOREA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 69 SOUTH KOREA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 70 SOUTH KOREA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 71 SOUTH KOREA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 72 INDIA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 73 INDIA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 74 INDIA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 75 INDIA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 76 INDIA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 77 INDIA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 78 INDIA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 79 INDIA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 80 INDIA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 81 SINGAPORE CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 82 SINGAPORE CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 83 SINGAPORE CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 84 SINGAPORE CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 85 SINGAPORE CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 86 SINGAPORE CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 87 SINGAPORE DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 88 SINGAPORE CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 89 SINGAPORE CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 90 AUSTRALIA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 91 AUSTRALIA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 92 AUSTRALIA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 93 AUSTRALIA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 94 AUSTRALIA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 95 AUSTRALIA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 96 AUSTRALIA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 97 AUSTRALIA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 98 AUSTRALIA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 99 THAILAND CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 100 THAILAND CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 101 THAILAND CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 102 THAILAND CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 103 THAILAND CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 104 THAILAND CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 105 THAILAND DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 106 THAILAND CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 107 THAILAND CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 108 MALAYSIA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 109 MALAYSIA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 110 MALAYSIA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 111 MALAYSIA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 112 MALAYSIA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 113 MALAYSIA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 114 MALAYSIA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 115 MALAYSIA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 116 MALAYSIA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 117 INDONESIA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 118 INDONESIA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 119 INDONESIA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 120 INDONESIA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 121 INDONESIA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 122 INDONESIA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 123 INDONESIA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 124 INDONESIA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 125 INDONESIA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 126 PHILIPPINES CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 127 PHILIPPINES CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 128 PHILIPPINES CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 129 PHILIPPINES CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 130 PHILIPPINES CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 131 PHILIPPINES CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 132 PHILIPPINES DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 133 PHILIPPINES CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 134 PHILIPPINES CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 135 REST OF ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 ASIA-PACIFIC CELL BASED ASSAYS MARKET
  • FIGURE 2 ASIA-PACIFIC CELL BASED ASSAYS MARKET: DATA VALIDATION MODEL
  • FIGURE 3 ASIA-PACIFIC CELL BASED ASSAYS MARKET: DROC ANALYSIS
  • FIGURE 4 ASIA-PACIFIC CELL BASED ASSAYS MARKET: ASIA-PACIFIC VS REGIONAL ANALYSIS
  • FIGURE 5 ASIA-PACIFIC CELL BASED ASSAYS MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 ASIA-PACIFIC CELL BASED ASSAYS MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 ASIA-PACIFIC CELL BASED ASSAYS MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 ASIA-PACIFIC CELL BASED ASSAYS MARKET: DBMR MARKET POSITION GRID (ON THE BASIS OF SERVICES)
  • FIGURE 9 ASIA-PACIFIC CELL BASED ASSAYS MARKET: DBMR VENDOR SHARE ANALYSIS (ON THE BASIS OF PRODUCTS)
  • FIGURE 10 ASIA-PACIFIC CELL BASED ASSAYS MARKET: DBMR VENDOR SHARE ANALYSIS (ON THE BASIS OF SERVICES)
  • FIGURE 11 DRIVERS, RESTRAINT, OPPORTUNITIES AND CHALLENGES OF THE ASIA-PACIFIC CELL BASED ASSAYS MARKET
  • FIGURE 12 WORLDWIDE BIOPHARMA COMPANIES R&D EXPENDITURE (IN MILLION U.S. DOLLARS)
  • FIGURE 13 ASIA-PACIFIC CELL BASED ASSAYS MARKET: SEGMENTATION
  • FIGURE 14 INCREASING INCIDENCE OF CHRONIC DISEASES AND RISING DEMANDS FOR NOVEL SMALL MOLECULES, BIO-THERAPEUTIC AND CELL BASED THERAPIES ARE EXPECTED TO DRIVE THE ASIA-PACIFIC CELL BASED ASSAYS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 15 CELL VIABILITY ASSAY IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC CELL BASED ASSAYS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 16 ASIA-PACIFIC IS THE MAXIMUM GROWING AND NORTH AMERICA IS THE MOST PROFITABLE REVENUE POCKETS FOR ASIA-PACIFIC CELL BASED ASSAYS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 17 ASIA-PACIFIC CELL BASED ASSAYS MARKET DOMINATED BY CELL VIABILITY ASSAY (2018)
  • FIGURE 18 ASIA-PACIFIC CELL BASED ASSAYS MARKET: BY TYPE, 2018
  • FIGURE 19 ASIA-PACIFIC CELL BASED ASSAYS MARKET: BY TYPE, CAGR (2019-2026)
  • FIGURE 20 ASIA-PACIFIC CELL BASED ASSAYS MARKET: BY TYPE, LIFELINE CURVE
  • FIGURE 21 ASIA-PACIFIC CELL BASED ASSAYS MARKET DOMINATED BY CONSUMABLES (2018)
  • FIGURE 22 ASIA-PACIFIC CELL BASED ASSAYS MARKET: BY PRODUCT & SERVICES, 2018
  • FIGURE 23 ASIA-PACIFIC CELL BASED ASSAYS MARKET: BY PRODUCT & SERVICES, CAGR (2019-2026)
  • FIGURE 24 ASIA-PACIFIC CELL BASED ASSAYS MARKET: BY PRODUCT & SERVICES, LIFELINE CURVE
  • FIGURE 25 ASIA-PACIFIC CELL BASED ASSAYS MARKET DOMINATED BY HIGH THROUGHPUT SCREENING (2018)
  • FIGURE 26 ASIA-PACIFIC CELL BASED ASSAYS MARKET: BY TECHNOLOGY, 2018
  • FIGURE 27 ASIA-PACIFIC CELL BASED ASSAYS MARKET: BY TECHNOLOGY, CAGR (2019-2026)
  • FIGURE 28 ASIA-PACIFIC CELL BASED ASSAYS MARKET: BY TECHNOLOGY, LIFELINE CURVE
  • FIGURE 29 ASIA-PACIFIC CELL BASED ASSAYS MARKET DOMINATED BY DRUG DISCOVERY (2018)
  • FIGURE 30 ASIA-PACIFIC CELL BASED ASSAYS MARKET: BY APPLICATION, 2018
  • FIGURE 31 ASIA-PACIFIC CELL BASED ASSAYS MARKET: BY APPLICATION, CAGR (2019-2026)
  • FIGURE 32 ASIA-PACIFIC CELL BASED ASSAYS MARKET: BY APPLICATION, LIFELINE CURVE
  • FIGURE 33 ASIA-PACIFIC CELL BASED ASSAYS MARKET DOMINATED BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES (2018)
  • FIGURE 34 ASIA-PACIFIC CELL BASED ASSAYS MARKET: BY END USER, 2018
  • FIGURE 35 ASIA-PACIFIC CELL BASED ASSAYS MARKET: BY END USER, CAGR (2019-2026)
  • FIGURE 36 ASIA-PACIFIC CELL BASED ASSAYS MARKET: BY END USER, LIFELINE CURVE
  • FIGURE 37 ASIA-PACIFIC CELL BASED ASSAYS MARKET DOMINATED BY DIRECT (2018)
  • FIGURE 38 ASIA-PACIFIC CELL BASED ASSAYS MARKET: BY DISTRIBUTION CHANNEL, 2018
  • FIGURE 39 ASIA-PACIFIC CELL BASED ASSAYS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2019-2026)
  • FIGURE 40 ASIA-PACIFIC CELL BASED ASSAYS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
  • FIGURE 41 ASIA-PACIFIC CELL BASED ASSAY MARKET: SNAPSHOT (2018)
  • FIGURE 42 ASIA-PACIFIC CELL BASED ASSAY MARKET: BY COUNTRY (2018)
  • FIGURE 43 ASIA-PACIFIC CELL BASED ASSAY MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 44 ASIA-PACIFIC CELL BASED ASSAY MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 45 ASIA-PACIFIC CELL BASED ASSAY MARKET: BY TYPE (2019-2026)
  • FIGURE 46 ASIA-PACIFIC CELL BASED ASSAYS MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 47 ASIA-PACIFIC CELL BASED ASSAYS MARKET: COMPANY SHARE 2018 (%)
Back to Top